LianBio (NASDAQ:LIAN) Stock Price Down 1.5% – Time to Sell?

Shares of LianBio (NASDAQ:LIAN) dropped 1.5% during trading on Thursday . The company traded as low as $0.20 and last traded at $0.20. Approximately 101,190 shares traded hands during mid-day trading, a decline of 90% from the average daily volume of 1,037,083 shares. The stock had previously closed at $0.20.

LianBio Price Performance

The stock has a market cap of $21.61 million, a P/E ratio of -0.25 and a beta of 0.23. The business’s fifty day moving average price is $0.23 and its 200 day moving average price is $0.28.

About LianBio

LianBio, a biopharmaceutical company, engages in developing and commercializing medicines for cardiovascular, oncology, opthalmology, and inflammatory diseases in China and other Asian countries. The company develops mavacamten for the treatment of obstructive and non-obstructive hypertrophic cardiomyopathy, and heart failure with preserved ejection fraction; TP-03 for the treatment of Demodex blepharitis and meibomian gland disease; NBTXR3 for the treatment of head and neck squamous cell carcinoma, and solid tumor; Infigratinib for the treatment of second-line and first-line cholangiocarcinoma, and gastric cancers; BBP-398 for solid tumors; Omilancor and NX-13 for ulcerative colitis and Crohn's disease; LYR-210 for chronic rhinosinusitis; and Sisunatovir for respiratory syncytical virus.